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Abstract 
Objective: To assess the reliability and validity of self- in the urine of 150 selected subjects. Results: Self-
reported opium use in a rural Iranian population at reported opiate use is reliable and valid in this pop-
high risk for esophageal cancer in preparation for a ulation. The reliability of ever opium use and duration 
large cohort study. Method: 1,057 subjects ages 33 to 84 of opium use had K’s of 0.96 and 0.74, respectively. 
years were recruited from Gonbad city and three The validity of self-reported opium use was also high. 
surrounding villages in Golestan province of Iran and Using urine codeine or morphine as the gold stan­
completed a questionnaire and provided biological dard for use of opium, self-report had a sensitivity 
samples. The history and duration of using opium, of 0.93 and a specificity of 0.89. Conclusions: The 
smoking tobacco, chewing nass, and drinking alcohol self-reported use of opium can provide a reliable 
were measured by questionnaire in the entire cohort. and valid measurement in this population and will 
A subgroup of 130 people was reinterviewed after be useful for studying associations between opium 
2 months to assess reliability. Validity of the opium use and occurrence of esophageal cancer and other 
question was assessed by comparing the questionnaire diseases. (Cancer Epidemiol Biomarkers Prev 2004; 
responses with the presence of codeine and morphine 13(6):1068–70) 
Introduction 
The population inhabiting the northeastern section of Iran 
near the coast of the Caspian Sea and the Turkmenistan 
border (mainly of Turkmen ethnicity) has some of the 
highest rates of esophageal squamous cell carcinoma in 
the world. Annual age standardized incidence rates of 93 
per 100,000 in men and 110 per 100,000 in women were 
reported in the 1970s in the area around Gonbad (1), and 
the high rates have been confirmed in more recent 
surveys (2). The cumulative mortality rate for the entire 
population approaches 1 in 6 (1), which is equivalent to 
the lung cancer rate in very heavy tobacco smokers in 
Western populations. The cause of these extraordinary 
rates has been investigated (3-5). The main risk factors 
suggested by these studies included a poor diet (marked 
by a reliance on tea and bread and a deficiency in fresh 
fruits, vegetables, and meat), consumption of hot tea, and 
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opium consumption. However, current evidence does 
not allow definitive conclusions. 
Opium is widely used in this population and has 
traditionally been consumed in Iran as a treatment for 
pain, diarrhea, and insomnia. Opium use was prohibited 
in 1955, and methadone and buprenorphine are available 
to registered addicts as part of treatment programs. Illicit 
opium use is thought to remain common. In Iran, opium 
is typically either eaten or smoked in one of three forms: 
(1) raw opium; (2) sukteh or opium dross, the pyrolized 
opium residue that is scraped from opium pipes; or (3) 
shireh, a refined opium product made by boiling either 
raw opium or sukteh and collecting the residue. An 
ecologic study across the northern part of Iran showed 
that areas with higher prevalence of opium use are 
coincident with higher rates of esophageal cancer (6). 
This study showed that among inhabitants over age 50 
years in high esophageal cancer incidence areas, 58% of 
men and 32% of women had >0.3 g/mL morphine in 
their urine. In low esophageal cancer incidence areas, the 
corresponding percentages were 14% in men and 12% in 
women. Within villages, opium use was more common 
among household members of esophageal cancer cases 
than among household members of noncases. 
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Table 1. Selected characteristics of study subjects 
overall and those with urine opiate measurements 
Variable Total Cohort Urine Subcohort* 
No. 1,057 150
 
Age, median (range) 49 (33-84) 46 (36-80)
 
Sex, female n (%) 610 (57.7) 30 (20.0)
 




Turkmen, n (%) 665 (62.9) 130 (86.7) 
Fars, n (%) 288 (27.3) 15 (10) 
Turk, n (%) 68 (6.4) 2 (1.3) 
Sistani, n (%) 21 (2.0) 0 (0) 
Other, n (%) 15 (1.4) 3 (2.0) 
Opium, n (%) ever 93 (8.8) 75 (50) 
Alcohol, n (%) ever 38 (3.8) 7 (4.7) 
Tobacco, n (%) ever 163 (15.4) 51 (34.0) 
Nass, n (%) ever 54 (5.1) 28 (18.7) 
*Subjects selected for the urine cohort were stratified on age, sex, place 
of residence, ethnicity, and whether they admitted opiate use by 
questionnaire. 
Self-reported illicit drug use has been widely investi­
gated and found to be reliable and usually valid (7, 8). 
Reliability, the likelihood of getting the same answer on 
two or more occasions, is typically high, ranging between 
0.80 and 0.95 (9). Validity, the accuracy or truthfulness of 
the answers received, can also be good but is lower than 
the range seen for reliability and can be very dependent 
on the setting (e.g., criminal justice vs. drug rehabilita­
tion/treatment) and the population studied. 
Recently, the IARC, the National Cancer Institute, 
and the Digestive Disease Research Center of Tehran 
University of Medical Sciences have begun joint studies 
to reexamine the etiology of esophageal cancer in 
northeastern Iran. In preparation for a large cohort 
study, we conducted a pilot study to test the recruitment 
of community members for an assessment of lifestyle and 
habits and the feasibility of collecting biological samples. 
In this article, we examine the reliability and validity of 
self-reported opium use to determine if it is sufficient for 
use in association studies. 
Methods 
Study Subjects and Recruitment. This study was 
conducted under the aegis of the ethical review panels 
of the IARC, the National Cancer Institute, and the 
Digestive Disease Research Center. Subjects for the study 
were selected from Gonbad city and three rural villages 
in the surrounding region of Golestan province. In 
Gonbad, 645 adults were sent a letter via their local 
health house informing them of the study and asking 
them to participate by attending their health house at a 
specific time for interview. Subjects (n = 438) subse­
quently attended and provided interview information 
and biological samples. In the three rural villages, 619 
individuals were successfully interviewed from the 682 
invited to visit the health house. In total, 1,057 subjects 
were enrolled into the study, an overall participation 
rate of 80%. The higher response rate among the rural 
inhabitants was thought to be due to their working close 
to home in agricultural occupations, which allowed 
greater flexibility to visit the health house. 
Questionnaire and Sample Collection. A broad-based 
questionnaire was administered to each participant by a 
local doctor recruited and trained by the study staff. The 
questions regarding opium (and tobacco, alcohol, and 
nass) use were ‘‘Have you ever used opium at least 
weekly over a 6-month period?’’ If the subject responded 
yes, they were asked to indicate the amount consumed in 
five categories from once a week to more than six times a 
day. The amount consumed was collected for distinct 
periods, by age, as defined by the respondent. Other 
variables were sex, place of residence (rural vs. urban), 
ethnicity. To assess reliability, 130 random subjects (80 
rural, 50 urban) were reinterviewed 2 months after the 
initial interview. 
Laboratory Analysis. At the time of recruitment, a 
spot urine sample was collected from all subjects and 
frozen. Subsequently, they were transferred from the 
cohort recruitment center to the biorepository at IARC, 
where they were kept at �20jC. Anonymized urine 
samples, from 150 cohort members comprising 75 
admitted opium users and an age, sex, residence, and 
ethnicity–matched group of 75 nonusers, were shipped 
to a commercial laboratory (American Toxicology Insti­
tute, Las Vegas, Nevada) on dry ice. Samples were 
screened for codeine and morphine using a proprietary 
immunoassay, and positive results were verified using 
gas chromatography-mass spectroscopy. Subjects with 
>500 ng/mL urine for either analyte were considered 
positive. All subjects positive in the first-stage immuno­
assay were above the 500 ng/mL cutoff in the gas 
chromatography-mass spectroscopy assay. 
Data Analysis. Data were tabulated for the total cohort 
and for members of the urine subcohort. We assessed 
reliability of questionnaire responses, using n , by com­
paring the first and second reports in the subgroup of 
130 subjects with repeated measurements. We assessed 
validity of self-reported opium use by comparing the re­
sults of the questionnaire to the results of the urine 
analysis (the gold standard) in the subgroup of 150 sub­
jects who had both measurements. 
Results 
Table 1 presents the characteristics of the 1,057 persons 
included in the study and the subgroup of 150 subjects 
Table 2. Reliability of self-reported substance use and 
duration of use 
Substance Agreement (%) Expected agreement (%) n 
Opium, ever use 99.3 83.5 0.96 
Opium, duration 83.3 35.4 0.74 
of use 
Tobacco, ever use 92.8 74.7 0.97 
Tobacco, duration 85.0 20.8 0.81 
of use 
Alcohol, ever use 99.3 89.7 0.93 
Alcohol, duration 71.4 26.5 0.61 
of use 
Nass, ever use 99.3 85.9 0.95 
Nass, duration 80.0 34.0 0.70 
of use 
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Table 3. Validity of self-reported opiate use compar­
ing questionnaire responses to urinalysis 
Urine Positive for 
Codeine or Morphine 
No Yes 
Self-reported use of opiates 
No 67 5 
Yes 8 70 
Operating characteristics of self-report 
Sensitivity (95% confidence interval) 0.93 (0.87-0.97) 
Specificity (95% confidence interval) 0.89 (0.83-0.93) 
included in the urine test cohort. Use of four different 
substances, all potentially associated with esophageal 
cancer, were assessed, including use of opium in any 
form, smoking tobacco, drinking alcohol, and chewing 
nass. Ever use of opium was reported by 8.8% of the 
study population. Smoking tobacco was reported by 15% 
of subjects, and use of alcohol or nass was rare. 
We assessed the reliability of the questionnaire for 
assessing self-reported substance use by reinterviewing 
a subgroup of 130 cohort members 2 months after the 
initial interview. The percentage agreement and the n 
statistic for ever use and duration of use of opium, 
tobacco, alcohol, or nass are reported in Table 2. All of 
the n statistics for ever use were >0.9 (excellent 
agreement), and all of the n statistics for duration of 
use were >0.6 (very good agreement). 
We tested the urine of 150 cohort subjects selected 
equally from subjects who did and did not report opiate 
use and who were matched on the age, sex, place of 
residence, and ethnicity to the users. We found a 
concordance rate of 91% (137 of 150) between self-report 
and urine positivity (Table 3). The sensitivity (95% con­
fidence interval) and specificity (95% confidence interval) 
of self-reported opium use were 93% (0.87-0.97) and 89% 
(0.83-0.93), respectively. 
Discussion 
Opium use was reported by 8.8% of all cohort members. 
Previous studies from this area reported that opium use 
in rural inhabitants ranged from 12% of females in the 
low cancer incidence area to 58% of men in the high 
incidence areas (6). The prevalence of use among rural 
men in the current study was 21%. Whether the apparent 
reduction in the prevalence of opium use during the last 
three decades is real cannot be assessed in this data 
set. However, other analgesics are now freely available 
through the network of health houses, and opium has 
become more difficult and expensive to obtain, so the 
reduction may be real. 
In our study, self-reported use of opium was very 
reliable, with a n of 0.96 between measurements sep­
arated by 2 months. Self-report of opium use was also 
valid. Using urine analysis of opium metabolites as a 
gold standard, we found that the questionnaire had a 
sensitivity of 93%. The lower specificity of self-reported 
opium use (89%) could be due to the relatively short time 
opium metabolites are present in the urine (2 to 4 days). 
The important conclusion from this analysis is that using 
a simple questionnaire produces a reliable and valid 
assessment of recent opium use in this population. 
Because opium is a traditional medicine in this 
population, and possibly because of the setting and per­
sonnel completing the interview, we suspect that there 
was little social pressure to deny use. The simplicity of 
the question favors a finding of high reliability and 
validity but may undermine our understanding of the 
association between opiate use and esophageal cancer, 
which may depend on the dose, form of opium used, and 
route of administration. Further work is warranted to 
determine our ability to assess other facets of opium use 
(i.e., opiate form, route of administration, etc.) by ques­
tionnaire. For our purposes, if we assume a 10% fre­
quency of opium use among the controls and set the true 
odds ratio for the association between opium use and 
esophageal squamous cell carcinoma at 2, 4, or 10, a 93% 
sensitive assessment of opiate use would reduce the 
apparent odds ratio to 1.99, 3.91, and 9.34, respectively. 
These small changes in the estimates for the disease 
association would not change the inference drawn from 
the results. 
Our finding that self-reported use of illicit drugs can 
be both reliable and valid is similar to reports from other 
populations (7, 8). Questionnaires should allow the in­
vestigation of the association between opiate use and di­
verse diseases in our population-based study and others. 
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